Tag: lymphoma

RA Experts Highlight Key Developments Over the Past Year

A massive Swedish cohort study suggesting that biologic agents reduce the known excess risk of lymphoma in patients with rheumatoid arthritis was hailed as one...

CAR T-cell Products Shine, Reveal New Insights

Real-world experience with chimeric antigen receptor (CAR) T-cell therapies for large B-cell lymphomas compares favorably with experience in commercial and trial settings and provides new...

FDA Approves Umbralisib (Ukoniq) for Two Lymphomas

The US Food and Drug Administration (FDA) has granted accelerated approval to umbralisib (Ukoniq) for the treatment of adults with relapsed or refractory marginal zone...

First CAR T-cell Tx for Mantle Cell Lymphoma Fills Unmet Need

The US Food and Drug Administration (FDA) granted accelerated approval on July 24, 2020, for the chimeric antigen receptor (CAR) T-cell therapy brexucabtagene autoleucel (Tecartus)...

Gait Speed May Improve Treatment Decisions in Elderly With Cancer

Gait speed testing might improve decisions about treatment intensity for people 75 years or older with blood cancer, say researchers. “The additional information this simple...

EMA OKs First CAR T-Cell Therapy for Mantle Cell Lymphoma

The European Medicines Agency (EMA) today recommended granting conditional marketing authorization to brexucabtagene autoleucel (Tecartus), making it the first approved chimeric antigen receptor (CAR) T-cell therapy for...

7 Things to Know About New Lymphoma Drug Tafasitamab

The US Food and Drug Administration (FDA) recently approved tafasitamab-cxix (Monjuvi) in combination with lenalidomide for the treatment of adults with relapsed or refractory diffuse...

Identifying Patients With Indolent Disease

Mantle cell lymphoma (MCL) can run the gamut from an indolent to aggressive disease, and identifying biomarkers is key in determining which patients should follow...

A father, a sister, a son: The blast in Beirut takes a heavy toll on Lebanon

BEIRUT: A close twin sister, now separated forever. An attentive and doting husband who sacrificed for his family and promised his wife the moon. A...

FDA Okays New CAR T Therapy, First for Mantle Cell Lymphoma

The US Food and Drug Administration (FDA) today granted accelerated approval to brexucabtagene autoleucel (Tecartus, Kite Pharma), the first approved chimeric antigen receptor (CAR) T cell therapy...

Home-Based Chemo Skyrockets at One US Center

In the fall of 2019, the University of Pennsylvania in Philadelphia started a pilot program of home-based chemotherapy for two treatment regimens (one via infusion...